Literature DB >> 9934550

Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection.

M Cormican1, D Morris, G Corbett-Feeeney, J Flynn.   

Abstract

We have evaluated the susceptibility of 199 pathogens isolated in pure culture from consecutive urine samples submitted from the community. Rates of susceptibility for all organisms were ampicillin, 48%; amoxycillin/clavulanic acid, 88%; cephalothin, 57%; cefuroxime axetil, 74%; nalidixic acid, 85%; ciprofloxacin, 99%; nitrofurantoin, 78%; and trimethoprim, 67%. Ciprofloxacin resistance and production of extended spectrum beta-lactamase enzymes were detected in Escherichia coli strains isolated from patients in the community.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9934550     DOI: 10.1016/s0732-8893(98)00113-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  Antibiotic Selection for Urinary Tract Infection: New Microbiologic Considerations.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice.

Authors:  C Quentin; C Arpin; V Dubois; C André; I Lagrange; I Fischer; J-P Brochet; F Grobost; J Jullin; B Dutilh; G Larribet; P Noury
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

4.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.

Authors:  G G Zhanel; J A Karlowsky; G K Harding; A Carrie; T Mazzulli; D E Low; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland.

Authors:  M Ni Chulain; A-M Murray; G Corbett-Feeney; M Cormican
Journal:  Ir J Med Sci       Date:  2005 Oct-Dec       Impact factor: 1.568

7.  Increasing Prevalence of Escherichia coli and Klebsiella pneumoniae Producing CTX-M-Type Extended-Spectrum Beta-Lactamase, Carbapenemase, and NDM-1 in Patients from a Rural Community with Community Acquired Infections: A 3-Year Study.

Authors:  Leimapokpam Sumitra Devi; Shobha Broor; Rajendra Singh Rautela; Shyam Sunder Grover; Anita Chakravarti; Debasish Chattopadhya
Journal:  Int J Appl Basic Med Res       Date:  2020-07-11

8.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers.

Authors:  Corinne Arpin; Véronique Dubois; Laure Coulange; Catherine André; Isabelle Fischer; Patrick Noury; Frédéric Grobost; Jean-Philippe Brochet; Jacqueline Jullin; Brigitte Dutilh; Gilberte Larribet; Isabelle Lagrange; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

9.  An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study.

Authors:  Menyfah Q Alanazi; Fulwah Y Alqahtani; Fadilah S Aleanizy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-02-09       Impact factor: 3.944

10.  Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine.

Authors:  Z Astal; F A Sharif; Soad A Abdallah; Mona I Fahd
Journal:  Ann Saudi Med       Date:  2004 Jan-Feb       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.